Companies that own Hugel Inc.
Morgan Stanley Investment Management Co.
194,524
4.46%
-40,328
3.26%
03/14/2018
Macquarie Funds Management Hong Kong Ltd.
156,272
3.59%
-20,651
3.13%
07/31/2018
AllianceBernstein LP
85,323
1.96%
250
0.02%
07/31/2018
Norges Bank Investment Management
83,888
1.93%
66,190
0.01%
12/31/2017
The Vanguard Group, Inc.
54,161
1.24%
3,541
0%
07/31/2018
Morgan Stanley Investment Management, Inc.
45,749
1.05%
-2,839
0.02%
07/31/2018
Waddell & Reed Investment Management Co.
42,116
0.97%
10,336
0.03%
06/30/2018
Columbia Management Investment Advisers LLC
36,726
0.84%
1,429
0.01%
05/31/2018
HSBC Global Asset Management (Hong Kong) Ltd.
28,616
0.66%
-7,975
0.12%
04/30/2018
William Blair Investment Management LLC
25,374
0.57%
-1,496
0.02%
07/31/2018
| Address |
61-20 Sinbuk-ro
Chuncheon-si GA 24206
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.hugel.co.kr |
| Updated |
09/14/2018 |
| Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea. |
